GoodRx Holdings (GDRX) Shares Crash 30% After Earnings and Guidance Miss, Prompting Several Downgrades
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to GoodRx Holdings (GDRX) Shares Crash 30% After Earnings and Guidance Miss, Prompting Several Downgrades
March 1, 2022 6:58 AM EST
Goldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $30.00 (from $43.00) while maintaining a Buy rating following results.
The analyst commented, "We reiterate our Buy rating but lower our PT from $43 to $30 to reflect both lowered operating... More
March 1, 2022 6:16 AM EST
RBC Capital analyst Mark Mahaney lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $35.00 (from $50.00) while maintaining a Outperform rating.... More
March 1, 2022 5:52 AM EST
BofA Securities analyst Justin Post lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $28.00 (from $42.00) while maintaining a Neutral rating.... More
March 1, 2022 4:58 AM EST
JPMorgan analyst Doug Anmuth lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $20.00 (from $33.00) while maintaining a Underweight rating.
The analyst comments "GoodRx is focused on building the top consumer-focused digital healthcare platform in the US. Its core offering tracks... More
March 1, 2022 4:32 AM EST
(Updated - March 1, 2022 5:00 AM EST)
Evercore ISI analyst Mark Mahaney lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $28.00 (from $47.00) while maintaining a Outperform rating.
The analyst comments "This was a very disappointing quarter. We had assumed that the company would be able to maintain its very impressive mid-30s% revenue growth, benefitting in part from very successful... More
